Skip to Main content Skip to Navigation
Journal articles

Low Dose Chest CT and Lung Ultrasound for the Diagnosis and Management of COVID-19

Abstract : Background: The COVID-19 pandemic has provided an opportunity to use low- and non-radiating chest imaging techniques on a large scale in the context of an infectious disease, which has never been done before. Previously, low-dose techniques were rarely used for infectious diseases, despite the recognised danger of ionising radiation. Method: To evaluate the role of low-dose computed tomography (LDCT) and lung ultrasound (LUS) in managing COVID-19 pneumonia, we performed a review of the literature including our cases. Results: Chest LDCT is now performed routinely when diagnosing and assessing the severity of COVID-19, allowing patients to be rapidly triaged. The extent of lung involvement assessed by LDCT is accurate in terms of predicting poor clinical outcomes in COVID-19-infected patients. Infectious disease specialists are less familiar with LUS, but this technique is also of great interest for a rapid diagnosis of patients with COVID-19 and is effective at assessing patient prognosis. Conclusions: COVID-19 is currently accelerating the transition to low-dose and “no-dose” imaging techniques to explore infectious pneumonia and their long-term consequences.
Complete list of metadata

https://hal-amu.archives-ouvertes.fr/hal-03282013
Contributor : Isabelle Combe <>
Submitted on : Thursday, July 8, 2021 - 4:13:03 PM
Last modification on : Thursday, August 5, 2021 - 4:04:41 PM

Links full text

Identifiers

Collections

Citation

Julie Finance, Laurent Zieleskewicz, Paul Habert, Alexis Jacquier, Philippe Parola, et al.. Low Dose Chest CT and Lung Ultrasound for the Diagnosis and Management of COVID-19. Journal of Clinical Medicine, MDPI, 2021, 10 (10), pp.2196. ⟨10.3390/jcm10102196⟩. ⟨hal-03282013⟩

Share

Metrics

Record views

20